Many Americans have chronic conditions that require regular treatments or medication to regulate symptoms like insulin for people with diabetes. The U.S. pharmaceutical industry uses federal support and discoveries to develop new treatments and kickstart the careers of new biomedical researchers.
Public servants working for you
Janet Woodcock, Food and Drug Administration
Transformed the Food and Drug Administration’s drug review process so that generic medications could become more common, reducing costs for patients. These changes also made promising treatments for severe, life-threatening diseases easier to access and have more quickly made lifesaving drugs available to patients.
At the CDC nearly one-third of the staff at the National Center for Chronic Disease Prevention and Health Promotion, which works to prevent the proliferation of chronic diseases and improve health outcomes, were fired as part of widespread workforce reductions.
PoliticoThe National Institutes of Health saw a $1.6 billion (20%) reduction in funding awards for research between January and April of 2025 compared to the same period in 2024, limiting financial support needed for clinical trials and new treatment research that can bring about breakthroughs in treating chronic health conditions.
New York TimesAfter a 20% reduction in force at the Food and Drug Administration, core functions like drug and clinical trial approval are facing significant delays, hindering drug development.
Wall Street Journal